Show latest about:
Keep settings
  Freetext search
 Market prices
 Technology guide
 Real estate
 Israel in depth
RSS  feeds
  Search results
Israeli startup Zebra Medical Vision raises $12m
The company currently offers algorithms supporting analysis of imaging results for osteoporosis, fatty liver, and emphysema.
Gali Weinreb   24 May 16   19:00

Aurum Ventures backs Hebrew U diagnostic platform
Via Yissum Research Development Company, Aurum is investing $1.2 million in a new approach to early detection of disease.
Globes correspondent   23 May 16   19:36

Israeli gov't grants stem cell co Gamida Cell $4.4m
Gamida Cell is developing cellular and immune therapies for the treatment of cancer and orphan genetic diseases.
Globes correspondent   23 May 16   19:15

Israeli cancer detection co Nucleix raises $3m
The company's first test for the detection of bladder cancer could be available in Europe within a couple of months.
Gali Weinreb   23 May 16   16:56

OrbiMed launches $307m second Israel fund
Globes correspondent   23 May 16   16:39

Baxter Ventures invests in Medasense Biometrics
Globes correspondent   23 May 16   14:28

Mayo Clinic to collaborate with Israeli startups
Globes correspondent   23 May 16   13:21

Personalized cancer drug co in AbbVie collaboration
Gali Weinreb   22 May 16   17:42

Teva CFO: We'll close Allergan deal next month
Shiri Habib-Valdhorn   22 May 16   16:30

Mazor to expand range of robotic surgical systems
Gali Weinreb   20 May 16   16:24

Oramed reports Phase IIb oral insulin trial success
Gali Weinreb   19 May 16   11:02

Mazor jumps in wake of Medtronic agreements
Moshe Golan   18 May 16   12:14

Ontario delegation signs Israel technology deals
Shay Niv   17 May 16   18:47

Teva's tax breaks in 2012-2013 NIS 6.4b
Eli Tsipori   17 May 16   13:36

"Our investors are aware of Israeli capabilities"
OrbiMed's partners are confident of high returns on their new $307 million Israel life sciences investment fund.
Gali Weinreb   24 May 16   14:26

New Kamada CEO optimistic despite European setback
Amir London believes the company will reach $100 million revenue in 2017, once its treatments are approved in the US and Europe.
Gali Weinreb    5 May 16   07:55

Pharma team seeks Israeli technologies
Novartis Global Strategic Partnership head Marie Lindner spoke to "Globes" ahead of her visit to Tel Aviv later this month.
Gali Weinreb    3 May 16   18:46

Drug cos funding for Israeli hospital research soars
Shay Niv   20 Apr 16   15:34

Israeli co ReWalk brings new hope to disabled veterans
Shahar Smooha    5 Jan 16   17:30

Teva CEO: We'll repay Allergan deal debt in 4 years
Hagai Golan    7 Dec 15   06:33